Committee staff report to the chairman and ranking member review of the FDA's approval process for the vagus nerve stimulation therapy system for treatment-resistant depression /

Saved in:

Bibliographic Details
Imprint:	Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2006.
Description:	iv, 386 p. : ill., digital, PDF file ;
Language:	English
Subject:	United States. -- Food and Drug Administration -- Rules and practice. Depression, Mental -- Treatment -- Government policy -- United States. Transcutaneous electrical nerve stimulation -- Therapeutic use -- Government policy -- United States. Vagus nerve.
Format:	E-Resource U.S. Federal Government Document Book
URL for this record:	http://pi.lib.uchicago.edu/1001/cat/bib/10630577

Hidden Bibliographic Details
Varying Form of Title:	Review of the FDA's approval process for the vagus nerve stimulation therapy system for treatment-resistant depression
Other uniform titles:	ProQuest U.S. Congressional Research Digital Collection.
Other authors / contributors:	United States. Congress. Senate. Committee on Finance.
Notes:	Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection. Reuse except for individual research requires license from ProQuest, LLC. Includes bibliographical references. Also available via Internet from the Finance Committee web site. Address as of 4/27/06: http://finance.senate.gov/press/Gpress/02%5F2006%20report.pdf; current access available via PURL. Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Research Digital Collection. Mode of access: World Wide Web via ProQuest website.
Other form:	Print version: Committee staff report to the chairman and ranking member 0160758777 Microfiche version: Committee staff report to the chairman and ranking member. [Bethesda, Md.] : ProQuest,[2004] CIS 2006 S362-3
GPO item no.:	1038-A 1038-A (online) 1038-B (MF) 1038-B (online)
Govt.docs classification:	Y 4.F 49:S.PRT.109-45

Similar Items